Lunit AI解决方案部署于全球3,500多个癌症筛查站点

The deployment of Lunit's AI solutions in over 3,500 sites globally represents a significant market penetration and validation of their technology in real-world clinical settings. This scale of adoption indicates growing trust and integration of AI in medical diagnostics, particularly for cancer screening. It suggests that Lunit's AI is proving effective in enhancing diagnostic performance, potentially leading to earlier and more accurate cancer detection, which can improve patient outcomes and reduce healthcare costs. This widespread use also positions Lunit as a leading player in the medical AI market, attracting further investment and partnerships.